Copyright Reports & Markets. All rights reserved.

Global Trazodone Hydrochloride (API) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Trazodone Hydrochloride (API) Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Trazodone Hydrochloride (API)
    • 1.3.3 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Trazodone Hydrochloride (API) Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Antidepression
    • 1.4.3 Anxiolytic
    • 1.4.4 Hypnotic
    • 1.4.5 Others
  • 1.5 Global Trazodone Hydrochloride (API) Market Size & Forecast
    • 1.5.1 Global Trazodone Hydrochloride (API) Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Trazodone Hydrochloride (API) Sales Quantity (2020-2031)
    • 1.5.3 Global Trazodone Hydrochloride (API) Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Teva
    • 2.1.1 Teva Details
    • 2.1.2 Teva Major Business
    • 2.1.3 Teva Trazodone Hydrochloride (API) Product and Services
    • 2.1.4 Teva Trazodone Hydrochloride (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Teva Recent Developments/Updates
  • 2.2 Angelini
    • 2.2.1 Angelini Details
    • 2.2.2 Angelini Major Business
    • 2.2.3 Angelini Trazodone Hydrochloride (API) Product and Services
    • 2.2.4 Angelini Trazodone Hydrochloride (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Angelini Recent Developments/Updates
  • 2.3 Mylan
    • 2.3.1 Mylan Details
    • 2.3.2 Mylan Major Business
    • 2.3.3 Mylan Trazodone Hydrochloride (API) Product and Services
    • 2.3.4 Mylan Trazodone Hydrochloride (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Mylan Recent Developments/Updates
  • 2.4 Fermion
    • 2.4.1 Fermion Details
    • 2.4.2 Fermion Major Business
    • 2.4.3 Fermion Trazodone Hydrochloride (API) Product and Services
    • 2.4.4 Fermion Trazodone Hydrochloride (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Fermion Recent Developments/Updates
  • 2.5 The Piramal Group
    • 2.5.1 The Piramal Group Details
    • 2.5.2 The Piramal Group Major Business
    • 2.5.3 The Piramal Group Trazodone Hydrochloride (API) Product and Services
    • 2.5.4 The Piramal Group Trazodone Hydrochloride (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 The Piramal Group Recent Developments/Updates

3 Competitive Environment: Trazodone Hydrochloride (API) by Manufacturer

  • 3.1 Global Trazodone Hydrochloride (API) Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Trazodone Hydrochloride (API) Revenue by Manufacturer (2020-2025)
  • 3.3 Global Trazodone Hydrochloride (API) Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Trazodone Hydrochloride (API) by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Trazodone Hydrochloride (API) Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Trazodone Hydrochloride (API) Manufacturer Market Share in 2024
  • 3.5 Trazodone Hydrochloride (API) Market: Overall Company Footprint Analysis
    • 3.5.1 Trazodone Hydrochloride (API) Market: Region Footprint
    • 3.5.2 Trazodone Hydrochloride (API) Market: Company Product Type Footprint
    • 3.5.3 Trazodone Hydrochloride (API) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Trazodone Hydrochloride (API) Market Size by Region
    • 4.1.1 Global Trazodone Hydrochloride (API) Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Trazodone Hydrochloride (API) Consumption Value by Region (2020-2031)
    • 4.1.3 Global Trazodone Hydrochloride (API) Average Price by Region (2020-2031)
  • 4.2 North America Trazodone Hydrochloride (API) Consumption Value (2020-2031)
  • 4.3 Europe Trazodone Hydrochloride (API) Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Trazodone Hydrochloride (API) Consumption Value (2020-2031)
  • 4.5 South America Trazodone Hydrochloride (API) Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Trazodone Hydrochloride (API) Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Trazodone Hydrochloride (API) Sales Quantity by Type (2020-2031)
  • 5.2 Global Trazodone Hydrochloride (API) Consumption Value by Type (2020-2031)
  • 5.3 Global Trazodone Hydrochloride (API) Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Trazodone Hydrochloride (API) Sales Quantity by Application (2020-2031)
  • 6.2 Global Trazodone Hydrochloride (API) Consumption Value by Application (2020-2031)
  • 6.3 Global Trazodone Hydrochloride (API) Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Trazodone Hydrochloride (API) Sales Quantity by Type (2020-2031)
  • 7.2 North America Trazodone Hydrochloride (API) Sales Quantity by Application (2020-2031)
  • 7.3 North America Trazodone Hydrochloride (API) Market Size by Country
    • 7.3.1 North America Trazodone Hydrochloride (API) Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Trazodone Hydrochloride (API) Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Trazodone Hydrochloride (API) Sales Quantity by Type (2020-2031)
  • 8.2 Europe Trazodone Hydrochloride (API) Sales Quantity by Application (2020-2031)
  • 8.3 Europe Trazodone Hydrochloride (API) Market Size by Country
    • 8.3.1 Europe Trazodone Hydrochloride (API) Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Trazodone Hydrochloride (API) Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Trazodone Hydrochloride (API) Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Trazodone Hydrochloride (API) Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Trazodone Hydrochloride (API) Market Size by Region
    • 9.3.1 Asia-Pacific Trazodone Hydrochloride (API) Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Trazodone Hydrochloride (API) Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Trazodone Hydrochloride (API) Sales Quantity by Type (2020-2031)
  • 10.2 South America Trazodone Hydrochloride (API) Sales Quantity by Application (2020-2031)
  • 10.3 South America Trazodone Hydrochloride (API) Market Size by Country
    • 10.3.1 South America Trazodone Hydrochloride (API) Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Trazodone Hydrochloride (API) Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Trazodone Hydrochloride (API) Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Trazodone Hydrochloride (API) Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Trazodone Hydrochloride (API) Market Size by Country
    • 11.3.1 Middle East & Africa Trazodone Hydrochloride (API) Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Trazodone Hydrochloride (API) Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Trazodone Hydrochloride (API) Market Drivers
  • 12.2 Trazodone Hydrochloride (API) Market Restraints
  • 12.3 Trazodone Hydrochloride (API) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Trazodone Hydrochloride (API) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Trazodone Hydrochloride (API)
  • 13.3 Trazodone Hydrochloride (API) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Trazodone Hydrochloride (API) Typical Distributors
  • 14.3 Trazodone Hydrochloride (API) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    Trazodone, a phenylpiperazine–triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.
    Trazodone hydrochloride is an antidepressant chemically unrelated to tricyclic, tetracyclic, or other known antidepressant agents. Trazodone hydrochloride is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl] propyl]-1,2,4-triazolo[4,3-a]pyridin-3 (2H)-one hydrochloride. It is a white odorless crystalline powder which is freely soluble in water.
    This report covers Trazodone Hydrochloride (API) (CAS Number: 25332-39-2) and Trazodone API (CAS Number: 19794-93-5).
    Trazodone hydrochloride (API) consumed in USA are mostly imported from overseas. Major companies are Angelini, Mylan, SST Corporation, The Piramal Group. The sales market share of the four companies has reached 53%. The local factory, Teva occupied about 40% market share.
    This report is a detailed and comprehensive analysis for global Trazodone Hydrochloride (API) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Trazodone Hydrochloride (API) market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
    Global Trazodone Hydrochloride (API) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
    Global Trazodone Hydrochloride (API) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
    Global Trazodone Hydrochloride (API) market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/Kg), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Trazodone Hydrochloride (API)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Trazodone Hydrochloride (API) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Angelini, Mylan, Fermion, The Piramal Group, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Trazodone Hydrochloride (API) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Trazodone Hydrochloride (API)
    Others
    Market segment by Application
    Antidepression
    Anxiolytic
    Hypnotic
    Others
    Major players covered
    Teva
    Angelini
    Mylan
    Fermion
    The Piramal Group
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Trazodone Hydrochloride (API) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Trazodone Hydrochloride (API), with price, sales quantity, revenue, and global market share of Trazodone Hydrochloride (API) from 2020 to 2025.
    Chapter 3, the Trazodone Hydrochloride (API) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Trazodone Hydrochloride (API) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Trazodone Hydrochloride (API) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Trazodone Hydrochloride (API).
    Chapter 14 and 15, to describe Trazodone Hydrochloride (API) sales channel, distributors, customers, research findings and conclusion.

    Buy now